Healthcare · Topic
Eu Gmp Annex I
2 articles from Healthcare practitioners
Pharma Manufacturing: Meeting Annex I with Precision Machining for Safer Sterile Drug Production
Pharmaceutical manufacturers are under increasing pressure to deliver sterile, high-quality medicines in smaller batches and faster cycles. As pharma manufacturing evolves, regulatory demands have intensified, especially following the 2023 revision of EU GMP Annex I, which places new emphasis on contamination control strategies, improved traceability, and minimizing human intervention throughout production. According to American…
Innovation and Excellence in Life Sciences: Benchmark Products’ Year in Review
A pharmaceutical manufacturer's advanced cleanroom operations and FDA-compliant bioprocessing solutions set new industry standards for durability and chemical r